Jeremie Botton

French National Agency for Medicines and Health Products Safety
Saint-Denis, France

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Use of Anxiolytic, Hypnotic and Antidepressant Drugs After Dispensation of a Levonorgestrel 52 mg Intra-uterine System Compared to a 19.5 mg Intra-uterine System: A Nationwide Matched-cohort Study

  Sunday, August 28, 2022
  2:45 PM – 3:00 PM CEST

• Assessment of the Risk of Myocardial Infarction, Stroke, and Pulmonary Embolism Following Different COVID-19 Vaccines in Adults Under 75 Years of Age in France

  Sunday, August 28, 2022
  2:15 PM – 2:30 PM CEST